TARDBP and Alzheimer disease: Interestingly, LATE is gaining recognition as a significant co‐pathology in Alzheimer's disease (AD), profoundly impacting disease progression and clinical outcomes, with 30–50% of AD cases showing TDP‐43 pathology, particularly among older individuals [48].